{"filing":{"accession_number":"0001104659-26-071195","cik":"0001162194","ticker":"LAB","company_name":"STANDARD BIOTOOLS INC.","form":"8-K","filing_date":"2026-06-08","report_date":null,"primary_document":"tm2617100d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465926071195/tm2617100d1_8k.htm"},"events":[{"id":6126,"run_id":5378,"accession_number":"0001104659-26-071195","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.97,"summary":"Standard BioTools entered into a definitive Merger Agreement with Treeline Biosciences on June 6, 2026, in an all-stock transaction valuing Treeline at $2.5 billion and Standard BioTools at $460 million, with Standard BioTools stockholders expected to hold approximately 16% of the combined company post-closing. The transaction constitutes a material change of control requiring stockholder approval and SEC registration.","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-08","form":"8-K","submitted_at":null,"items":[{"id":5076,"accession_number":"0001104659-26-071195","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"Standard BioTools entered into a definitive Merger Agreement with Treeline Biosciences on June 6, 2026, pursuant to which the two companies will combine in an all-stock merger. The transaction values Treeline at $2.5 billion and Standard BioTools at $460 million, with former Standard BioTools stockholders expected to hold approximately 16% of the combined company post-closing. This is a material acquisition/change of control transaction requiring stockholder approval and SEC registration, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:32:18.147395+00:00","company_name":"","ticker":null,"filing_date":""},{"id":5078,"accession_number":"0001104659-26-071195","item_number":"5.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Item 5.01 discloses a \"Changes in Control of Registrant\" and explicitly incorporates Item 1.01 by reference. Item 1.01 covers material acquisitions and other transactions resulting in a change of control. This is a material event affecting ownership and control of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:32:18.147395+00:00","company_name":"","ticker":null,"filing_date":""},{"id":5080,"accession_number":"0001104659-26-071195","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the execution of a Merger Agreement between Standard BioTools and Treeline on June 8, 2026, announced via joint press release. The Item 7.01 disclosure references the \"Transactions\" and describes a material acquisition/merger event, including discussion of stockholder approval requirements, CVR consideration, and the combined company's expected trading on Nasdaq. This is a core M\u0026A activity event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:32:18.147395+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":6127,"run_id":5378,"accession_number":"0001104659-26-071195","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"Standard BioTools will issue unregistered Common Stock in connection with the Merger Agreement, relying on Section 4(a)(2) and Regulation D exemptions. This equity issuance materially affects shareholder ownership and capital structure.","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-08","form":"8-K","submitted_at":null,"items":[{"id":5077,"accession_number":"0001104659-26-071195","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses unregistered issuance of Standard BioTools Common Stock in connection with a Merger, relying on Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive private placement scenario where equity securities are being issued without public registration, which materially affects shareholder ownership and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:32:18.147395+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5076,"accession_number":"0001104659-26-071195","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.99,"reasoning":"Standard BioTools entered into a definitive Merger Agreement with Treeline Biosciences on June 6, 2026, pursuant to which the two companies will combine in an all-stock merger. The transaction values Treeline at $2.5 billion and Standard BioTools at $460 million, with former Standard BioTools stockholders expected to hold approximately 16% of the combined company post-closing. This is a material acquisition/change of control transaction requiring stockholder approval and SEC registration, clearly falling under Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:32:18.147395+00:00","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-08"},{"id":5077,"accession_number":"0001104659-26-071195","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses unregistered issuance of Standard BioTools Common Stock in connection with a Merger, relying on Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive private placement scenario where equity securities are being issued without public registration, which materially affects shareholder ownership and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:32:18.147395+00:00","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-08"},{"id":5078,"accession_number":"0001104659-26-071195","item_number":"5.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"Item 5.01 discloses a \"Changes in Control of Registrant\" and explicitly incorporates Item 1.01 by reference. Item 1.01 covers material acquisitions and other transactions resulting in a change of control. This is a material event affecting ownership and control of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:32:18.147395+00:00","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-08"},{"id":5079,"accession_number":"0001104659-26-071195","item_number":"5.02","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.35,"reasoning":"Item 5.02 incorporates Item 1.01 by reference but provides no substantive disclosure of executive departures, appointments, or compensation arrangements in the section itself. Without access to Item 1.01's content, the materiality and specific event type cannot be reliably determined; the incorporation-by-reference structure suggests the actual event is disclosed elsewhere in the filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:32:18.147395+00:00","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-08"},{"id":5080,"accession_number":"0001104659-26-071195","item_number":"7.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the execution of a Merger Agreement between Standard BioTools and Treeline on June 8, 2026, announced via joint press release. The Item 7.01 disclosure references the \"Transactions\" and describes a material acquisition/merger event, including discussion of stockholder approval requirements, CVR consideration, and the combined company's expected trading on Nasdaq. This is a core M\u0026A activity event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T12:32:18.147395+00:00","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-08"}]}